國立高雄大學圖資館 |

Language: English

Back

Frontiers of biostatistical methods ...

Crowley, John.

Frontiers of biostatistical methods and applications in clinical oncology

Record Type:	Electronic resources : Monograph/item
Title/Author:	Frontiers of biostatistical methods and applications in clinical oncologyedited by Shigeyuki Matsui, John Crowley.
other author:	Matsui, Shigeyuki.
Published:	Singapore :Springer Singapore :2017.
Description:	xiii, 438 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
Subject:	Biometry.
Online resource:	http://dx.doi.org/10.1007/978-981-10-0126-0
ISBN:	9789811001260$q(electronic bk.)

Frontiers of biostatistical methods and applications in clinical oncology
Frontiers of biostatistical methods and applications in clinical oncology[electronic resource] /edited by Shigeyuki Matsui, John Crowley. - Singapore :Springer Singapore :2017. - xiii, 438 p. :ill., digital ;24 cm.

1. Phase I clinical trials -- 2. Phase II clinical trials -- 3. Phase III clinical trials -- 4. Evaluation of surrogate endpoints -- 5. Disease Screening/development of diagnosis -- 6. Analysis of omics data (genomic signature developments etc) -- 7. Causal inference in clinical trials and observational studies.

This book presents the state of the art of biostatistical methods and their applications in clinical oncology. Many methodologies established today in biostatistics have been brought about through its applications to the design and analysis of oncology clinical studies. This field of oncology, now in the midst of evolution owing to rapid advances in biotechnologies and cancer genomics, is becoming one of the most promising disease fields in the shift toward personalized medicine. Modern developments of diagnosis and therapeutics of cancer have also been continuously fueled by recent progress in establishing the infrastructure for conducting more complex, large-scale clinical trials and observational studies. The field of cancer clinical studies therefore will continue to provide many new statistical challenges that warrant further progress in the methodology and practice of biostatistics. This book provides a systematic coverage of various stages of cancer clinical studies. Topics from modern cancer clinical trials include phase I clinical trials for combination therapies, exploratory phase II trials with multiple endpoints/treatments, and confirmative biomarker-based phase III trials with interim monitoring and adaptation. It also covers important areas of cancer screening, prognostic analysis, and the analysis of large-scale molecular data in the era of big data.

ISBN: 9789811001260$q(electronic bk.)

Standard No.: 10.1007/978-981-10-0126-0doiSubjects--Topical Terms:

182039
Biometry.

LC Class. No.: QH323.5 / .F76 2017

Dewey Class. No.: 570.15195

Frontiers of biostatistical methods and applications in clinical oncology
LDR:02634nmm a2200289 a 4500 001 523661
003 DE-He213
005 20180426170541.0
006 m d
007 cr nn 008maaau
008 180628s2017 si s 0 eng d
020 $a 9789811001260$q(electronic bk.)
020 $a 9789811001246$q(paper)
024 7 $a 10.1007/978-981-10-0126-0 $2 doi
035 $a 978-981-10-0126-0
040 $a GP $c GP
041 0 $a eng
050 4 $a QH323.5 $b .F76 2017
082 0 4 $a 570.15195 $2 23
090 $a QH323.5 $b .F935 2017
245 0 0 $a Frontiers of biostatistical methods and applications in clinical oncology $h [electronic resource] / $c edited by Shigeyuki Matsui, John Crowley.
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2017.
300 $a xiii, 438 p. : $b ill., digital ; $c 24 cm.
505 0 $a 1. Phase I clinical trials -- 2. Phase II clinical trials -- 3. Phase III clinical trials -- 4. Evaluation of surrogate endpoints -- 5. Disease Screening/development of diagnosis -- 6. Analysis of omics data (genomic signature developments etc) -- 7. Causal inference in clinical trials and observational studies.
520 $a This book presents the state of the art of biostatistical methods and their applications in clinical oncology. Many methodologies established today in biostatistics have been brought about through its applications to the design and analysis of oncology clinical studies. This field of oncology, now in the midst of evolution owing to rapid advances in biotechnologies and cancer genomics, is becoming one of the most promising disease fields in the shift toward personalized medicine. Modern developments of diagnosis and therapeutics of cancer have also been continuously fueled by recent progress in establishing the infrastructure for conducting more complex, large-scale clinical trials and observational studies. The field of cancer clinical studies therefore will continue to provide many new statistical challenges that warrant further progress in the methodology and practice of biostatistics. This book provides a systematic coverage of various stages of cancer clinical studies. Topics from modern cancer clinical trials include phase I clinical trials for combination therapies, exploratory phase II trials with multiple endpoints/treatments, and confirmative biomarker-based phase III trials with interim monitoring and adaptation. It also covers important areas of cancer screening, prognostic analysis, and the analysis of large-scale molecular data in the era of big data.
650 0 $a Biometry. $3 182039
650 1 4 $a Statistics. $3 182057
650 2 4 $a Statistics for Life Sciences, Medicine, Health Sciences. $3 274067
650 2 4 $a Statistical Theory and Methods. $3 274054
650 2 4 $a Statistics for Social Science, Behavorial Science, Education, Public Policy, and Law. $3 274394
700 1 $a Matsui, Shigeyuki. $3 794999
700 1 $a Crowley, John. $3 795000
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-981-10-0126-0
950 $a Mathematics and Statistics (Springer-11649)